Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.

American journal of hematology - 1 Nov 2007

Vairaktaris Eleftherios, Yapijakis Christos, Nkenke Emeka, Vassiliou Stavros, Vylliotis Antonis, Nixon Alexander Michael, Derka Spyridoula, Ragos Vasilis, Spyridonidou Sofia, Tsigris Christos, Neukam Friedrich W, Patsouris Efstratios

Abstract excerpt

No studies thus far have investigated the contribution of thrombin activatable fibrinolysis inhibitor (TAFI) to oral oncogenesis. We studied the activity-related 1040C/T polymorphism in 150 patients with oral cancer and 138 healthy controls matched by age, gender, and ethnicity. The increased-activity T allele frequency was significantly reduced in patients compared with controls (28.7% vs. 37.0%, P < 0.05). T/T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carboxypeptidase B2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Case-Control Studies

Share to Germany

Share to Greece

Share to Homozygote

Share to Mouth Neoplasms

Source

Identifiers

PMID: 17636471
DOI: 10.1002/ajh.20985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The 1040C/T polymorphism influencing thermal stability and activity of thrombin activatable fibrinolysis inhibitor is associated with risk for oral cancer.PMID 17636471Read ↗

Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.Semantic proximity Read ↗

Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system.Semantic proximity Read ↗

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.Semantic proximity Read ↗

Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer.Semantic proximity Read ↗

Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans.Semantic proximity Read ↗

Increased risk for oral cancer is associated with coagulation factor XIII but not with factor XII.Semantic proximity Read ↗

Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.Semantic proximity Read ↗

The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer.Semantic proximity Read ↗

Angiotensinogen polymorphism is associated with risk for malignancy but not for oral cancer.Semantic proximity Read ↗

The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.Semantic proximity Read ↗

Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.